カテゴリー： 世界, 医療/バイオ, LP Information

世界の酒石酸水素リバスチグミン市場予測 2023年-2029年

【英語タイトル】Global Rivastigmine Bitartrate Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00288）・商品コード：LP23DC00288
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：98
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の酒石酸水素リバスチグミン市場」は、過去の販売実績から2022年の世界の酒石酸水素リバスチグミンの総販売量を検討し、2023年から2029年の予測される酒石酸水素リバスチグミンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の酒石酸水素リバスチグミンの市場規模を掲載し、XXX百万米ドル規模の世界の酒石酸水素リバスチグミン市場の詳細な分析を提供します。本インサイトレポートは、世界の酒石酸水素リバスチグミン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の酒石酸水素リバスチグミン市場における各社の独自のポジションをより深く理解するために、酒石酸水素リバスチグミン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の酒石酸水素リバスチグミン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。酒石酸水素リバスチグミンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。酒石酸水素リバスチグミンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。酒石酸水素リバスチグミンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

酒石酸水素リバスチグミンの世界主要メーカーとしては、Sun Pharmaceutical、 Novartis、 Siegfried Barberà S.L.、 Zhejiang Jingxin Pharmaceutical Co., Ltd.、 Beijing Sihuan Pharmaceutical Co., Ltd.、 WanTe Pharmaceutical (Jiangsu) Co., Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の酒石酸水素リバスチグミン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では酒石酸水素リバスチグミン市場をセグメンテーションし、種類別 (錠剤、カプセル)、用途別 (病院、クリニック、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：錠剤、カプセル

・用途別区分：病院、クリニック、薬局、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の酒石酸水素リバスチグミン市場の10年間の市場状況・展望は？
・世界および地域別に見た酒石酸水素リバスチグミン市場成長の要因は何か？
・酒石酸水素リバスチグミンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・酒石酸水素リバスチグミンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：酒石酸水素リバスチグミンの年間販売量2018-2029、地域別現状・将来分析
・酒石酸水素リバスチグミンの種類別セグメント：錠剤、カプセル
・酒石酸水素リバスチグミンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・酒石酸水素リバスチグミンの用途別セグメント：病院、クリニック、薬局、その他
・酒石酸水素リバスチグミンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の酒石酸水素リバスチグミン市場
・企業別のグローバル酒石酸水素リバスチグミン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の酒石酸水素リバスチグミンの年間売上：2018-2023年の売上、市場シェア
・企業別の酒石酸水素リバスチグミン販売価格
・主要企業の酒石酸水素リバスチグミン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

酒石酸水素リバスチグミンの地域別レビュー
・地域別の酒石酸水素リバスチグミン市場規模2018-2023：年間販売量、売上
・主要国別の酒石酸水素リバスチグミン市場規模2018-2023：年間販売量、売上
・南北アメリカの酒石酸水素リバスチグミン販売の成長
・アジア太平洋の酒石酸水素リバスチグミン販売の成長
・ヨーロッパの酒石酸水素リバスチグミン販売の成長
・中東・アフリカの酒石酸水素リバスチグミン販売の成長

南北アメリカ市場
・南北アメリカの国別の酒石酸水素リバスチグミン販売量、売上（2018-2023）
・南北アメリカの酒石酸水素リバスチグミンの種類別販売量
・南北アメリカの酒石酸水素リバスチグミンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の酒石酸水素リバスチグミン販売量、売上（2018-2023）
・アジア太平洋の酒石酸水素リバスチグミンの種類別販売量
・アジア太平洋の酒石酸水素リバスチグミンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の酒石酸水素リバスチグミン販売量、売上（2018-2023）
・ヨーロッパの酒石酸水素リバスチグミンの種類別販売量
・ヨーロッパの酒石酸水素リバスチグミンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の酒石酸水素リバスチグミン販売量、売上（2018-2023）
・中東・アフリカの酒石酸水素リバスチグミンの種類別販売量
・中東・アフリカの酒石酸水素リバスチグミンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・酒石酸水素リバスチグミンの製造コスト構造分析
・酒石酸水素リバスチグミンの製造プロセス分析
・酒石酸水素リバスチグミンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・酒石酸水素リバスチグミンの主要なグローバル販売業者
・酒石酸水素リバスチグミンの主要なグローバル顧客

地域別の酒石酸水素リバスチグミン市場予測レビュー
・地域別の酒石酸水素リバスチグミン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・酒石酸水素リバスチグミンの種類別市場規模予測
・酒石酸水素リバスチグミンの用途別市場規模予測

主要企業分析
Sun Pharmaceutical、 Novartis、 Siegfried Barberà S.L.、 Zhejiang Jingxin Pharmaceutical Co., Ltd.、 Beijing Sihuan Pharmaceutical Co., Ltd.、 WanTe Pharmaceutical (Jiangsu) Co., Ltd.
・企業情報
・酒石酸水素リバスチグミン製品
・酒石酸水素リバスチグミン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Rivastigmine Bitartrate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rivastigmine Bitartrate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rivastigmine Bitartrate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rivastigmine Bitartrate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rivastigmine Bitartrate players cover Sun Pharmaceutical, Novartis, Siegfried Barberà S.L., Zhejiang Jingxin Pharmaceutical Co., Ltd., Beijing Sihuan Pharmaceutical Co., Ltd. and WanTe Pharmaceutical (Jiangsu) Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Rivastigmine bitartrate is used to treat the symptoms of mild to moderate Alzheimer’s dementia. It is a carbamate drug that selectively acts on acetyl and butyrylcholinesterase inhibitors in the brain, thereby delaying the degradation of acetylcholine released by fully functional cholinergic neurons, and ultimately promoting cholinergic nerve conduction.
LPI (LP Information)’ newest research report, the “Rivastigmine Bitartrate Industry Forecast” looks at past sales and reviews total world Rivastigmine Bitartrate sales in 2022, providing a comprehensive analysis by region and market sector of projected Rivastigmine Bitartrate sales for 2023 through 2029. With Rivastigmine Bitartrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rivastigmine Bitartrate industry.
This Insight Report provides a comprehensive analysis of the global Rivastigmine Bitartrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rivastigmine Bitartrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rivastigmine Bitartrate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rivastigmine Bitartrate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rivastigmine Bitartrate.
This report presents a comprehensive overview, market shares, and growth opportunities of Rivastigmine Bitartrate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablet
Capsules
Segmentation by application
Hospital
Clinic
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Sun Pharmaceutical
Novartis
Siegfried Barberà S.L.
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Beijing Sihuan Pharmaceutical Co., Ltd.
WanTe Pharmaceutical (Jiangsu) Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rivastigmine Bitartrate market?
What factors are driving Rivastigmine Bitartrate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rivastigmine Bitartrate market opportunities vary by end market size?
How does Rivastigmine Bitartrate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rivastigmine Bitartrate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rivastigmine Bitartrate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rivastigmine Bitartrate by Country/Region, 2018, 2022 & 2029
2.2 Rivastigmine Bitartrate Segment by Type
2.2.1 Tablet
2.2.2 Capsules
2.3 Rivastigmine Bitartrate Sales by Type
2.3.1 Global Rivastigmine Bitartrate Sales Market Share by Type (2018-2023)
2.3.2 Global Rivastigmine Bitartrate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rivastigmine Bitartrate Sale Price by Type (2018-2023)
2.4 Rivastigmine Bitartrate Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Rivastigmine Bitartrate Sales by Application
2.5.1 Global Rivastigmine Bitartrate Sale Market Share by Application (2018-2023)
2.5.2 Global Rivastigmine Bitartrate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rivastigmine Bitartrate Sale Price by Application (2018-2023)
3 Global Rivastigmine Bitartrate by Company
3.1 Global Rivastigmine Bitartrate Breakdown Data by Company
3.1.1 Global Rivastigmine Bitartrate Annual Sales by Company (2018-2023)
3.1.2 Global Rivastigmine Bitartrate Sales Market Share by Company (2018-2023)
3.2 Global Rivastigmine Bitartrate Annual Revenue by Company (2018-2023)
3.2.1 Global Rivastigmine Bitartrate Revenue by Company (2018-2023)
3.2.2 Global Rivastigmine Bitartrate Revenue Market Share by Company (2018-2023)
3.3 Global Rivastigmine Bitartrate Sale Price by Company
3.4 Key Manufacturers Rivastigmine Bitartrate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rivastigmine Bitartrate Product Location Distribution
3.4.2 Players Rivastigmine Bitartrate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rivastigmine Bitartrate by Geographic Region
4.1 World Historic Rivastigmine Bitartrate Market Size by Geographic Region (2018-2023)
4.1.1 Global Rivastigmine Bitartrate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rivastigmine Bitartrate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rivastigmine Bitartrate Market Size by Country/Region (2018-2023)
4.2.1 Global Rivastigmine Bitartrate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rivastigmine Bitartrate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rivastigmine Bitartrate Sales Growth
4.4 APAC Rivastigmine Bitartrate Sales Growth
4.5 Europe Rivastigmine Bitartrate Sales Growth
4.6 Middle East & Africa Rivastigmine Bitartrate Sales Growth
5 Americas
5.1 Americas Rivastigmine Bitartrate Sales by Country
5.1.1 Americas Rivastigmine Bitartrate Sales by Country (2018-2023)
5.1.2 Americas Rivastigmine Bitartrate Revenue by Country (2018-2023)
5.2 Americas Rivastigmine Bitartrate Sales by Type
5.3 Americas Rivastigmine Bitartrate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rivastigmine Bitartrate Sales by Region
6.1.1 APAC Rivastigmine Bitartrate Sales by Region (2018-2023)
6.1.2 APAC Rivastigmine Bitartrate Revenue by Region (2018-2023)
6.2 APAC Rivastigmine Bitartrate Sales by Type
6.3 APAC Rivastigmine Bitartrate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rivastigmine Bitartrate by Country
7.1.1 Europe Rivastigmine Bitartrate Sales by Country (2018-2023)
7.1.2 Europe Rivastigmine Bitartrate Revenue by Country (2018-2023)
7.2 Europe Rivastigmine Bitartrate Sales by Type
7.3 Europe Rivastigmine Bitartrate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rivastigmine Bitartrate by Country
8.1.1 Middle East & Africa Rivastigmine Bitartrate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rivastigmine Bitartrate Revenue by Country (2018-2023)
8.2 Middle East & Africa Rivastigmine Bitartrate Sales by Type
8.3 Middle East & Africa Rivastigmine Bitartrate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rivastigmine Bitartrate
10.3 Manufacturing Process Analysis of Rivastigmine Bitartrate
10.4 Industry Chain Structure of Rivastigmine Bitartrate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rivastigmine Bitartrate Distributors
11.3 Rivastigmine Bitartrate Customer
12 World Forecast Review for Rivastigmine Bitartrate by Geographic Region
12.1 Global Rivastigmine Bitartrate Market Size Forecast by Region
12.1.1 Global Rivastigmine Bitartrate Forecast by Region (2024-2029)
12.1.2 Global Rivastigmine Bitartrate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rivastigmine Bitartrate Forecast by Type
12.7 Global Rivastigmine Bitartrate Forecast by Application
13 Key Players Analysis
13.1 Sun Pharmaceutical
13.1.1 Sun Pharmaceutical Company Information
13.1.2 Sun Pharmaceutical Rivastigmine Bitartrate Product Portfolios and Specifications
13.1.3 Sun Pharmaceutical Rivastigmine Bitartrate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sun Pharmaceutical Main Business Overview
13.1.5 Sun Pharmaceutical Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Rivastigmine Bitartrate Product Portfolios and Specifications
13.2.3 Novartis Rivastigmine Bitartrate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Siegfried Barberà S.L.
13.3.1 Siegfried Barberà S.L. Company Information
13.3.2 Siegfried Barberà S.L. Rivastigmine Bitartrate Product Portfolios and Specifications
13.3.3 Siegfried Barberà S.L. Rivastigmine Bitartrate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Siegfried Barberà S.L. Main Business Overview
13.3.5 Siegfried Barberà S.L. Latest Developments
13.4 Zhejiang Jingxin Pharmaceutical Co., Ltd.
13.4.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
13.4.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Product Portfolios and Specifications
13.4.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Main Business Overview
13.4.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Latest Developments
13.5 Beijing Sihuan Pharmaceutical Co., Ltd.
13.5.1 Beijing Sihuan Pharmaceutical Co., Ltd. Company Information
13.5.2 Beijing Sihuan Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Product Portfolios and Specifications
13.5.3 Beijing Sihuan Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Sihuan Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Beijing Sihuan Pharmaceutical Co., Ltd. Latest Developments
13.6 WanTe Pharmaceutical (Jiangsu) Co., Ltd.
13.6.1 WanTe Pharmaceutical (Jiangsu) Co., Ltd. Company Information
13.6.2 WanTe Pharmaceutical (Jiangsu) Co., Ltd. Rivastigmine Bitartrate Product Portfolios and Specifications
13.6.3 WanTe Pharmaceutical (Jiangsu) Co., Ltd. Rivastigmine Bitartrate Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 WanTe Pharmaceutical (Jiangsu) Co., Ltd. Main Business Overview
13.6.5 WanTe Pharmaceutical (Jiangsu) Co., Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rivastigmine Bitartrate Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rivastigmine Bitartrate Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsules
Table 5. Global Rivastigmine Bitartrate Sales by Type (2018-2023) & (K Units)
Table 6. Global Rivastigmine Bitartrate Sales Market Share by Type (2018-2023)
Table 7. Global Rivastigmine Bitartrate Revenue by Type (2018-2023) & ($ million)
Table 8. Global Rivastigmine Bitartrate Revenue Market Share by Type (2018-2023)
Table 9. Global Rivastigmine Bitartrate Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Rivastigmine Bitartrate Sales by Application (2018-2023) & (K Units)
Table 11. Global Rivastigmine Bitartrate Sales Market Share by Application (2018-2023)
Table 12. Global Rivastigmine Bitartrate Revenue by Application (2018-2023)
Table 13. Global Rivastigmine Bitartrate Revenue Market Share by Application (2018-2023)
Table 14. Global Rivastigmine Bitartrate Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Rivastigmine Bitartrate Sales by Company (2018-2023) & (K Units)
Table 16. Global Rivastigmine Bitartrate Sales Market Share by Company (2018-2023)
Table 17. Global Rivastigmine Bitartrate Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Rivastigmine Bitartrate Revenue Market Share by Company (2018-2023)
Table 19. Global Rivastigmine Bitartrate Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Rivastigmine Bitartrate Producing Area Distribution and Sales Area
Table 21. Players Rivastigmine Bitartrate Products Offered
Table 22. Rivastigmine Bitartrate Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rivastigmine Bitartrate Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Rivastigmine Bitartrate Sales Market Share Geographic Region (2018-2023)
Table 27. Global Rivastigmine Bitartrate Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Rivastigmine Bitartrate Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Rivastigmine Bitartrate Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Rivastigmine Bitartrate Sales Market Share by Country/Region (2018-2023)
Table 31. Global Rivastigmine Bitartrate Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Rivastigmine Bitartrate Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Rivastigmine Bitartrate Sales by Country (2018-2023) & (K Units)
Table 34. Americas Rivastigmine Bitartrate Sales Market Share by Country (2018-2023)
Table 35. Americas Rivastigmine Bitartrate Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Rivastigmine Bitartrate Revenue Market Share by Country (2018-2023)
Table 37. Americas Rivastigmine Bitartrate Sales by Type (2018-2023) & (K Units)
Table 38. Americas Rivastigmine Bitartrate Sales by Application (2018-2023) & (K Units)
Table 39. APAC Rivastigmine Bitartrate Sales by Region (2018-2023) & (K Units)
Table 40. APAC Rivastigmine Bitartrate Sales Market Share by Region (2018-2023)
Table 41. APAC Rivastigmine Bitartrate Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Rivastigmine Bitartrate Revenue Market Share by Region (2018-2023)
Table 43. APAC Rivastigmine Bitartrate Sales by Type (2018-2023) & (K Units)
Table 44. APAC Rivastigmine Bitartrate Sales by Application (2018-2023) & (K Units)
Table 45. Europe Rivastigmine Bitartrate Sales by Country (2018-2023) & (K Units)
Table 46. Europe Rivastigmine Bitartrate Sales Market Share by Country (2018-2023)
Table 47. Europe Rivastigmine Bitartrate Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Rivastigmine Bitartrate Revenue Market Share by Country (2018-2023)
Table 49. Europe Rivastigmine Bitartrate Sales by Type (2018-2023) & (K Units)
Table 50. Europe Rivastigmine Bitartrate Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Rivastigmine Bitartrate Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Rivastigmine Bitartrate Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Rivastigmine Bitartrate Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Rivastigmine Bitartrate Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rivastigmine Bitartrate Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Rivastigmine Bitartrate Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Rivastigmine Bitartrate
Table 58. Key Market Challenges & Risks of Rivastigmine Bitartrate
Table 59. Key Industry Trends of Rivastigmine Bitartrate
Table 60. Rivastigmine Bitartrate Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Rivastigmine Bitartrate Distributors List
Table 63. Rivastigmine Bitartrate Customer List
Table 64. Global Rivastigmine Bitartrate Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Rivastigmine Bitartrate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Rivastigmine Bitartrate Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Rivastigmine Bitartrate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Rivastigmine Bitartrate Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Rivastigmine Bitartrate Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Rivastigmine Bitartrate Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Rivastigmine Bitartrate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Rivastigmine Bitartrate Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Rivastigmine Bitartrate Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Rivastigmine Bitartrate Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Rivastigmine Bitartrate Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Rivastigmine Bitartrate Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Rivastigmine Bitartrate Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sun Pharmaceutical Basic Information, Rivastigmine Bitartrate Manufacturing Base, Sales Area and Its Competitors
Table 79. Sun Pharmaceutical Rivastigmine Bitartrate Product Portfolios and Specifications
Table 80. Sun Pharmaceutical Rivastigmine Bitartrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sun Pharmaceutical Main Business
Table 82. Sun Pharmaceutical Latest Developments
Table 83. Novartis Basic Information, Rivastigmine Bitartrate Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis Rivastigmine Bitartrate Product Portfolios and Specifications
Table 85. Novartis Rivastigmine Bitartrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Novartis Main Business
Table 87. Novartis Latest Developments
Table 88. Siegfried Barberà S.L. Basic Information, Rivastigmine Bitartrate Manufacturing Base, Sales Area and Its Competitors
Table 89. Siegfried Barberà S.L. Rivastigmine Bitartrate Product Portfolios and Specifications
Table 90. Siegfried Barberà S.L. Rivastigmine Bitartrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Siegfried Barberà S.L. Main Business
Table 92. Siegfried Barberà S.L. Latest Developments
Table 93. Zhejiang Jingxin Pharmaceutical Co., Ltd. Basic Information, Rivastigmine Bitartrate Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhejiang Jingxin Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Product Portfolios and Specifications
Table 95. Zhejiang Jingxin Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Zhejiang Jingxin Pharmaceutical Co., Ltd. Main Business
Table 97. Zhejiang Jingxin Pharmaceutical Co., Ltd. Latest Developments
Table 98. Beijing Sihuan Pharmaceutical Co., Ltd. Basic Information, Rivastigmine Bitartrate Manufacturing Base, Sales Area and Its Competitors
Table 99. Beijing Sihuan Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Product Portfolios and Specifications
Table 100. Beijing Sihuan Pharmaceutical Co., Ltd. Rivastigmine Bitartrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Beijing Sihuan Pharmaceutical Co., Ltd. Main Business
Table 102. Beijing Sihuan Pharmaceutical Co., Ltd. Latest Developments
Table 103. WanTe Pharmaceutical (Jiangsu) Co., Ltd. Basic Information, Rivastigmine Bitartrate Manufacturing Base, Sales Area and Its Competitors
Table 104. WanTe Pharmaceutical (Jiangsu) Co., Ltd. Rivastigmine Bitartrate Product Portfolios and Specifications
Table 105. WanTe Pharmaceutical (Jiangsu) Co., Ltd. Rivastigmine Bitartrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. WanTe Pharmaceutical (Jiangsu) Co., Ltd. Main Business
Table 107. WanTe Pharmaceutical (Jiangsu) Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Rivastigmine Bitartrate
Figure 2. Rivastigmine Bitartrate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rivastigmine Bitartrate Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rivastigmine Bitartrate Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rivastigmine Bitartrate Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Capsules
Figure 11. Global Rivastigmine Bitartrate Sales Market Share by Type in 2022
Figure 12. Global Rivastigmine Bitartrate Revenue Market Share by Type (2018-2023)
Figure 13. Rivastigmine Bitartrate Consumed in Hospital
Figure 14. Global Rivastigmine Bitartrate Market: Hospital (2018-2023) & (K Units)
Figure 15. Rivastigmine Bitartrate Consumed in Clinic
Figure 16. Global Rivastigmine Bitartrate Market: Clinic (2018-2023) & (K Units)
Figure 17. Rivastigmine Bitartrate Consumed in Retail Pharmacy
Figure 18. Global Rivastigmine Bitartrate Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 19. Rivastigmine Bitartrate Consumed in Others
Figure 20. Global Rivastigmine Bitartrate Market: Others (2018-2023) & (K Units)
Figure 21. Global Rivastigmine Bitartrate Sales Market Share by Application (2022)
Figure 22. Global Rivastigmine Bitartrate Revenue Market Share by Application in 2022
Figure 23. Rivastigmine Bitartrate Sales Market by Company in 2022 (K Units)
Figure 24. Global Rivastigmine Bitartrate Sales Market Share by Company in 2022
Figure 25. Rivastigmine Bitartrate Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Rivastigmine Bitartrate Revenue Market Share by Company in 2022
Figure 27. Global Rivastigmine Bitartrate Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Rivastigmine Bitartrate Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Rivastigmine Bitartrate Sales 2018-2023 (K Units)
Figure 30. Americas Rivastigmine Bitartrate Revenue 2018-2023 ($ Millions)
Figure 31. APAC Rivastigmine Bitartrate Sales 2018-2023 (K Units)
Figure 32. APAC Rivastigmine Bitartrate Revenue 2018-2023 ($ Millions)
Figure 33. Europe Rivastigmine Bitartrate Sales 2018-2023 (K Units)
Figure 34. Europe Rivastigmine Bitartrate Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Rivastigmine Bitartrate Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Rivastigmine Bitartrate Revenue 2018-2023 ($ Millions)
Figure 37. Americas Rivastigmine Bitartrate Sales Market Share by Country in 2022
Figure 38. Americas Rivastigmine Bitartrate Revenue Market Share by Country in 2022
Figure 39. Americas Rivastigmine Bitartrate Sales Market Share by Type (2018-2023)
Figure 40. Americas Rivastigmine Bitartrate Sales Market Share by Application (2018-2023)
Figure 41. United States Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Rivastigmine Bitartrate Sales Market Share by Region in 2022
Figure 46. APAC Rivastigmine Bitartrate Revenue Market Share by Regions in 2022
Figure 47. APAC Rivastigmine Bitartrate Sales Market Share by Type (2018-2023)
Figure 48. APAC Rivastigmine Bitartrate Sales Market Share by Application (2018-2023)
Figure 49. China Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Rivastigmine Bitartrate Sales Market Share by Country in 2022
Figure 57. Europe Rivastigmine Bitartrate Revenue Market Share by Country in 2022
Figure 58. Europe Rivastigmine Bitartrate Sales Market Share by Type (2018-2023)
Figure 59. Europe Rivastigmine Bitartrate Sales Market Share by Application (2018-2023)
Figure 60. Germany Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Rivastigmine Bitartrate Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Rivastigmine Bitartrate Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Rivastigmine Bitartrate Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Rivastigmine Bitartrate Sales Market Share by Application (2018-2023)
Figure 69. Egypt Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Rivastigmine Bitartrate Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Rivastigmine Bitartrate in 2022
Figure 75. Manufacturing Process Analysis of Rivastigmine Bitartrate
Figure 76. Industry Chain Structure of Rivastigmine Bitartrate
Figure 77. Channels of Distribution
Figure 78. Global Rivastigmine Bitartrate Sales Market Forecast by Region (2024-2029)
Figure 79. Global Rivastigmine Bitartrate Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Rivastigmine Bitartrate Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Rivastigmine Bitartrate Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Rivastigmine Bitartrate Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Rivastigmine Bitartrate Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の酒石酸水素リバスチグミン市場予測 2023年-2029年] (コード：LP23DC00288)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の酒石酸水素リバスチグミン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の酒石酸水素メタラミノールAPI市場予測 2023年-2029年
  • 世界の医薬品用酒石酸水素ノルエピネフリン市場予測 2023年-2029年
  • 世界の医薬品用インドブフェン市場予測 2023年-2029年
  • 世界の医薬品用ベンズブロマロン市場予測 2023年-2029年
  • 世界の医薬品用カベルゴリン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆